secwatch.observer — SEC 8-K summary
======================================

Issuer:     Breeze Holdings Acquisition Corp. (—)
CIK:        0001817640
Form:       8-K/A
Filed at:   2025-03-21T23:59:59+00:00
Accession:  0001013762-25-000980
Event type: regulatory
Sentiment:  negative
Materiality: 0.50
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Breeze Holdings corrects OTCQX deficiency: rights/warrants only; common stock unaffected
--------------------------------------------------------------------------------

- Company received March 17, 2025 OTCQX deficiency for rights (BRZHR) and warrants (BRZHW) under penny stock exemption rules.
- Original 8-K incorrectly cited common stock; this amendment corrects that the deficiency pertains only to rights and warrants.
- Company has 90 days to cure, until June 13, 2025.
- Breeze Holdings expects to close business combination with YD Biopharma Limited before the deadline; combined company would list on NASDAQ.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817640/000101376225000980/0001013762-25-000980-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817640/000101376225000980/ea0235255-8ka_breeze.htm
  HTML page:      https://secwatch.observer/filing/0001013762-25-000980

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer